ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,532, issued on Feb. 24, was assigned to STICHTING AMSTERDAM UMC (Amsterdam).

"Embryonic angiogenesis markers and diagnostic and therapeutic strategies based thereon" was invented by Arjan Willem Griffioen (Amsterdam), Elisabeth Johanna Maria Huijbers (Amsterdam) and Patrycja Nowak-Sliwinska (Amsterdam).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is in the field of medicine. More specifically, it is in the field of diagnosing tumor angiogenesis status and in the field of medical treatment of a subject who is suffering, suspected to suffer, or might suffer from a tumor in the future. In particular, the invention relates to a fusion pol...